Searched for
ISRAELI DRUG MAKER
Weight is over! Pharma companies race to make weight-loss drug semaglutideIndian drugmakers, including Dr. Reddy's and Zydus Lifesciences, are investing heavily in manufacturing capabilities to launch generic vers...- Glenmark to pay $30 million in an antitrust settlement in US over cholesterol drug pricingThe company in an exchange notification said that it has entered into a three-year deferred prosecution agreement, and if the company adher...
- Marksans Pharma acquires Teva's manufacturing site in GoaThe manufacturing site is spread across 47,597 sq meters and has approvals to manufacture products from EU, Health Canada and Japanese Heal...
- Dr Reddy's gearing up to get substantial slice of Revlimid generic opportunity in USRevlimid is a top-selling cancer drug from Bristol Myers Squibb. Its generic form, called lenalidomide, is seen as Dr Reddy's most anticipa...
- Submitted proposal to DCGI to test Sputnik Light as Covid booster dose: Dr Reddy's"As regards to Sputnik, we are now ready with capacities in India. We are working actively with the Government of India for registering Spu...
- Dr Reddy's lines up Rs 1,000 crore capex for current fiscal yearThe Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal year.
- Dr Reddy's in talks with RDIF on Sputnik V for other countriesDr Reddy's which had received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for pilo...
- Aurobindo Pharma may buy Portugal's Generis, deal likely to be valued at $200 millionAurobindo's latest bid comes on the heels of last month’s shot at Israeli drug maker Teva's UK product portfolio, where it was outbid by ri...
- Teva may move court against Dr Reddy's for patent infringementThe Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.
- Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US marketThe company is also recalling 7,694 bottles of anti- inflammatory drug indomethacin 25 mg, produced by Emcure Pharma, for non-adherence to ...
- US Patents rejects Teva's plea on Copaxone; Natco shares upHyderabad-based Natco markets Copaxone (Glatiramer Acetate) -- used in the treatment of relapsing-remitting multiple sclerosis -- in the US...
- Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
- Pharmaceutical companies should consider mergers: Dilip ShanghviPharmaceutical companies, who are battling growing competition from each other and resurgent multinationals, may have to shake hands.
- Sun Pharma buys controlling stake in Taro, shares upSun Pharmaceuticals today said it has acquired a controlling stake in Israeli pharma major Taro Pharmaceuticals.
- Taro accuses Sun of waging proxy warIsraeli drug maker Taro Pharma has alleged that Sun Pharma is attempting to seize its control by waging a proxy war.
- Sun Pharma extends open offer to April 17, 2009Sun Pharmaceutical Industries has extended the open offer for acquiring shares of Israeli drug maker Taro Pharmaceutical which was schedule...
- Sun Pharma extends open offer to April 3, 2009Sun Pharmaceutical Industries has extended the open offer, which was to expire today, for acquiring shares of Israeli drug maker Taro Pharm...
- Sun Pharma extends Taro open offer till October 3Drug maker Sun Pharmaceuticals open offer for purchase of all outstanding shares of Taro has been extended to October 3 with a possibility ...
- Indian drug makers eye US firm Par PharmaIndia's top drug makers are in the race to acquire US-based generic drug maker, Par Pharmaceutical Co Inc, two Indian newspapers reported o...
- Sun may hike offer for Taro stakeSun Pharmaceutical Industries, which has been struggling over the last few months to gain control over Israel’s Taro Pharmaceutical Industr...
Load More
